Home › Triple-Negative Breast Cancer › Georgia › Augusta
Triple-Negative Breast Cancer clinical trials in Augusta, GA
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Augusta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- Augusta University, Augusta
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- Augusta University Georgia Cancer Center, Augusta
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
RecruitingPhase 1/2
- Georgia Cancer Center, Augusta
Triple-Negative Breast Cancer trials in other cities
- Houston, TX42 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- St. Louis, MO21 studies
- Atlanta, GA20 studies
- Arlington, VA20 studies
- Dallas, TX18 studies
- Chicago, IL16 studies
- Columbus, OH16 studies
Other studies in Augusta
- Acute Myeloid Leukemia10 studies
- Ovarian Cancer8 studies
- Endometrial Cancer7 studies
- Cancer (all types)7 studies
- Sickle Cell Disease5 studies
- Breast Cancer5 studies
- Myasthenia Gravis4 studies
- Blood Cancers4 studies
- Burkitt Lymphoma4 studies
- Diffuse Large B-Cell Lymphoma4 studies
- Chronic Myeloid Leukemia4 studies
- Non-Hodgkin Lymphoma4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.